Research

Ayahuasca assisted Psychotherapy for the Prevention of Prolonged Grief
From a constructivist perspective, grief is a process of rebuilding a world that has been torn apart by loss. Ayahuasca, on the other hand, promotes experiences that broaden our understanding of the human being and nature.
I want to participate in the study

About the study

The COVID-19 pandemic has taken millions of lives around the world, making it difficult to say goodbye and accompany our loved ones in their last days and giving rise to multiple situations that are difficult to process emotionally.

True to its social commitment, Fundación Beckley Med is making available a study to evaluate the potential of ayahuasca assisted by constructivist psychotherapy in the prevention of prolonged bereavement.

The enrolment period for participants will be open from 2021 to 2024, with the aim of serving 216 people who have lost a first-degree relative in the last 12 months.

This study is led by Dr. Debora Gonzalez and has been approved by the HU-GTiP ethics committee (IRB Ref.: PI-19-188).

Inclusion and exclusion criteria

Inclusion
Men and women between 18 and 65 years of age
Who have lost a first-degree relative
A maximum of 12 months have passed since the death of their relative.
Exclusion
Pregnant or breastfeeding women
Cardiovascular disorders
Psychotic disorder or history of psychotic disorder
Bipolar disorder or history of such disorder
Psychotropic substance and alcohol abuse
Receiving regular pharmacological or psychological therapy for the treatment of prolonged bereavement during the study.

Débora González
Débora González holds a degree in Psychology (UAM) and a PhD in Pharmacology (UAB, Extraordinary Prize). She has published several articles on the pharmacology of 2C-B, Salvia divinorum and ayahuasca. She is currently researching the potential of ayahuasca as a therapeutic tool in the process of mourning the death of a loved one.
I want to participate in the study
Other research that may interest you
See All Research
Our partners
Beckley Med’s training offer articulated courses from three of the world’s leading institutions in psychedelic therapy

Think Tank founded in Great Britain in 1998 by Amanda Feilding, a pioneer in psychedelic research in the field of mental health and on Drug Policy reform.

The world’s leading psychedelic research organisation. Rick Doblin’s MAPS is a global leader in training programmes for psychedelic therapists.

The figure of Stan Grof in the history of psychedelics has reached legendary status. His legacy takes the form of a comprehensive psychedelic psychotherapy training programme.

¿Quieres recibir las novedades
de Beckley Med?

Esta web está protegida por reCAPTCHA. La política de privacidad y los términos del servicio de Google son aplicables.

Would you like to receive the latest news from Beckley Med?

This website is protected by reCAPTCHA. Google's privacy policy and terms of service apply.